Published in Biotech Law Weekly, July 2nd, 2004
This follows the filing of a lawsuit by the state of New York against GSK: The state accuses the company of fraud, by depriving consumers of the information they and their doctors need to make informed decisions about treatment, and seeks the return of all profits obtained through fraudulent means.
The editorial was published in the June 12, 2004, issue of the Lancet.
Paroxetine is not licensed for use by adolescents or children in the U.S. or Europe; however, "off-label" prescribing is not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.